|
|
||||||||||
|
J Am Coll Cardiol, 1987; 10:756-760 © 1987 by the American College of Cardiology Foundation |
Department of Medicine, Francis Scott Key Medical Center, Baltimore, Maryland 21224.
Silent myocardial ischemia as detected on Holter electrocardiographic (ECG) monitoring is present in greater than 50% of patients with unstable angina despite intensive medical therapy. The presence and the extent of silent ischemia have been correlated with an increased risk of early (1 month) unfavorable outcome including myocardial infarction and need for coronary revascularization for persistent symptoms. Seventy patients with unstable angina who had undergone continuous ECG monitoring for silent ischemia were followed up for 2 years; 37 patients (Group I) had Holter ECG evidence of silent ischemia at bed rest in the coronary care unit during medical treatment with nitrates, beta-receptor blockers and calcium channel antagonists; the other 33 patients (Group II) had no ischemic ST segment changes (symptomatic or silent) on Holter monitoring. Over a 2 year follow-up period, myocardial infarction occurred in 10 patients in Group I (in 2 it was fatal) compared with one nonfatal infarction in Group II (p less than 0.01 by Kaplan-Meier analysis); revascularization with either coronary bypass surgery or angioplasty for symptomatic ischemia was performed in 11 Group I and 5 Group II patients (p less than 0.05). Multivariate Cox's hazard analysis demonstrated that the presence of silent ischemia was the best predictor of 2 year outcome. Therefore, persistent silent myocardial ischemia despite medical therapy in patients with unstable angina carries adverse prognostic implications that persist over a 2 year period.
This article has been cited by other articles:
![]() |
B. J. Drew, R. M. Califf, M. Funk, E. S. Kaufman, M. W. Krucoff, M. M. Laks, P. W. Macfarlane, C. Sommargren, S. Swiryn, and G. F. Van Hare Practice Standards for Electrocardiographic Monitoring in Hospital Settings: An American Heart Association Scientific Statement From the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: Endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses Circulation, October 26, 2004; 110(17): 2721 - 2746. [Abstract] [Full Text] [PDF] |
||||
![]() |
B L Norgaard, K Andersen, K Thygesen, J Ravkilde, P Abrahamsson, L Grip, and M Dellborg Long term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring Heart, July 1, 2004; 90(7): 739 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Moreno, A. Villate, J. Zamorano, C. Almeria, J.-A. Perez-Gonzalez, J.-L. Rodrigo, L. P. de Isla, L. Mataix, and C. Macaya Identifying patients without favourable long-term outcome among those with medically stabilized unstable angina and a negative dipyridamole stress echocardiogram Eur J Echocardiogr, June 1, 2004; 5(3): 205 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Cohn, K. M. Fox, and C. Daly Silent Myocardial Ischemia Circulation, September 9, 2003; 108(10): 1263 - 1277. [Full Text] [PDF] |
||||
![]() |
S. G. Goodman, D. Fitchett, P. W. Armstrong, M. Tan, A. Langer, and for the Integrilin and Enoxaparin Randomized Asses Randomized Evaluation of the Safety and Efficacy of Enoxaparin Versus Unfractionated Heparin in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Receiving the Glycoprotein IIb/IIIa Inhibitor Eptifibatide Circulation, January 21, 2003; 107(2): 238 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Adams-Hamoda, M. A. Caldwell, N. A. Stotts, and B. J. Drew Factors to Consider When Analyzing 12-Lead Electrocardiograms for Evidence of Acute Myocardial Ischemia Am. J. Crit. Care., January 1, 2003; 12(1): 9 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Kennon, C P Price, P G Mills, P K MacCallum, J Cooper, J Hooper, H Clarke, and A D Timmis Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers Heart, January 1, 2003; 89(1): 36 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Pelter, M. G. Adams, and B. J. Drew Association of Transient Myocardial Ischemia With Adverse In-Hospital Outcomes for Angina Patients Treated in a Telemetry Unit or a Coronary Care Unit Am. J. Crit. Care., July 1, 2002; 11(4): 318 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.J. Drew, M.M. Pelter, and M.G. Adams Frequency, characteristics, and clinical significance of transient ST segment elevation in patients with acute coronary syndromes Eur. Heart J., June 2, 2002; 23(12): 941 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Schulman, D. R. Thiemann, P. Ouyang, N. C. Chandra, D. S. Schulman, S. E. Reis, M. Terrin, S. Forman, C. Piva de Albuquerque, R. D. Bahr, et al. Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina J. Am. Coll. Cardiol., January 16, 2002; 39(2): 231 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Valensi, R.-N. Sachs, B. Harfouche, B. Lormeau, J. Paries, E. Cosson, F. Paycha, M. Leutenegger, and J.-R. Attali Predictive Value of Cardiac Autonomic Neuropathy in Diabetic Patients With or Without Silent Myocardial Ischemia Diabetes Care, February 1, 2001; 24(2): 339 - 343. [Abstract] [Full Text] |
||||
![]() |
S. G. Goodman, A. Barr, A. Sobtchouk, M. Cohen, G. J. Fromell, L. Laperriere, C. Hill, A. Langer, and for the Canadian Efficacy and Safety of Subcutaneo Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1507 - 1513. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Weber, H. Schneider, T. von Arnim, and W. Urbaszek Heart rate variability and ischaemia in patients with coronary heart disease and stable angina pectoris: Influence of drug therapy and prognostic value Eur. Heart J., January 1, 1999; 20(1): 38 - 50. [Abstract] [PDF] |
||||
![]() |
D. T. Mangano, E. L. Layug, A. Wallace, I. Tateo, and The Multicenter Study of Perioperative Ischemia Re Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery N. Engl. J. Med., December 5, 1996; 335(23): 1713 - 1721. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Schulman, P. J. Goldschmidt-Clermont, E. J. Topol, R. M. Califf, F. I. Navetta, J. T. Willerson, N. C. Chandra, A. D. Guerci, J. J. Ferguson, R. A. Harrington, et al. Effects of Integrelin, a Platelet Glycoprotein IIb/IIIa Receptor Antagonist, in Unstable Angina: A Randomized Multicenter Trial Circulation, November 1, 1996; 94(9): 2083 - 2089. [Abstract] [Full Text] |
||||
![]() |
F. L. Dini, C. Volterrani, A. Giaconi, A. Azzarelli, M. Lunardi, and D. Bernardi Prior Myocardial Infarction and Prognostic Outcome in Patients with Unstable Angina in a Postdischarge Follow-up Angiology, April 1, 1996; 47(4): 321 - 327. [Abstract] [PDF] |
||||
![]() |
J. B. Gill, J. A. Cairns, R. S. Roberts, L. Costantini, B. J. Sealey, E. F. Fallen, C. W. Tomlinson, and M. Gent Prognostic Importance of Myocardial Ischemia Detected by Ambulatory Monitoring Early after Acute Myocardial Infarction N. Engl. J. Med., January 11, 1996; 334(2): 65 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liuzzo, L. M. Biasucci, J. R. Gallimore, R. L. Grillo, A. G. Rebuzzi, M. B. Pepys, and A. Maseri The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina N. Engl. J. Med., August 18, 1994; 331(7): 417 - 424. [Abstract] [Full Text] |
||||
![]() |
W. S. Aronow, S. Epstein, and M. Koenigsberg Usefulness of Echocardiographic Left Ventricular Hypertrophy and Silent Ischemia in Predicting New Cardiac Events in Elderly Patients With Systemic Hypertension or Coronary Artery Disease Angiology, March 1, 1990; 41(3): 189 - 193. [Abstract] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |